Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

Heqet: regenerating heart muscle cells via the Hippo pathway

King’s College spinout is inducing cardiomyocyte regeneration via nanoparticle-delivered miRNA

By Danielle Golovin, Staff Writer
June 4, 2022 12:44 AM UTC

Turin-based Heqet is using miRNA compounds that transiently modulate the Hippo-YAP pathway to regenerate damaged heart tissue.

Heqet Therapeutics s.r.l. founder Mauro Giacca discovered Hippo pathway-modulating miRNAs while at the  International Centre for Genetic Engineering and Biotechnology (ICGEB) Trieste studying mechanisms of regeneration. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

2invest AG

4basebio AG

Claris Ventures

Heqet Therapeutics s.r.l.

International Centre for Genetic Engineering and Biotechnology

Inventiva S.A.

King's College London